Literature DB >> 35726018

Microsatellite instability in gastrointestinal cancers.

Giovanni Corso1,2,3.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35726018      PMCID： PMC9437054          DOI： 10.1038/s41431-022-01134-6

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN： 1018-4813            Impact factor:   5.351


× No keyword cloud information.
  9 in total

1.  MSI phenotype and MMR alterations in familial and sporadic gastric cancer.

Authors:  Marina Leite; Giovanni Corso; Sónia Sousa; Fernanda Milanezi; Luís P Afonso; Rui Henrique; José Manuel Soares; Sérgio Castedo; Fátima Carneiro; Franco Roviello; Carla Oliveira; Raquel Seruca
Journal:  Int J Cancer       Date:  2010-06-07       Impact factor: 7.396

Review 2.  KRAS signaling pathway alterations in microsatellite unstable gastrointestinal cancers.

Authors:  Sérgia Velho; Giovanni Corso; Carla Oliveíra; Raquel Seruca
Journal:  Adv Cancer Res       Date:  2010       Impact factor: 6.242

3.  Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial.

Authors:  Kei Muro; Hyun Cheol Chung; Veena Shankaran; Ravit Geva; Daniel Catenacci; Shilpa Gupta; Joseph Paul Eder; Talia Golan; Dung T Le; Barbara Burtness; Autumn J McRee; Chia-Chi Lin; Kumudu Pathiraja; Jared Lunceford; Kenneth Emancipator; Jonathan Juco; Minori Koshiji; Yung-Jue Bang
Journal:  Lancet Oncol       Date:  2016-05-03       Impact factor: 41.316

4.  Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study.

Authors:  Luis A Diaz; Kai-Keen Shiu; Tae-Won Kim; Benny Vittrup Jensen; Lars Henrik Jensen; Cornelis Punt; Denis Smith; Rocio Garcia-Carbonero; Manuel Benavides; Peter Gibbs; Christelle de la Fourchardiere; Fernando Rivera; Elena Elez; Dung T Le; Takayuki Yoshino; Wen Yan Zhong; David Fogelman; Patricia Marinello; Thierry Andre
Journal:  Lancet Oncol       Date:  2022-04-12       Impact factor: 54.433

5.  Association of microsatellite instability (MSI) status with the 5-year outcome and genetic ancestry in a large Brazilian cohort of colorectal cancer.

Authors:  Gustavo Noriz Berardinelli; Ronílson Durães; Allini Mafra da Costa; Arinilda Bragagnoli; Marco Antônio de Oliveira; Rui Pereira; Cristovam Scapulatempo-Neto; Denise Peixoto Guimarães; Rui Manuel Reis
Journal:  Eur J Hum Genet       Date:  2022-04-26       Impact factor: 5.351

6.  Correlation of microsatellite instability at multiple loci with long-term survival in advanced gastric carcinoma.

Authors:  Giovanni Corso; Corrado Pedrazzani; Daniele Marrelli; Valeria Pascale; Enrico Pinto; Franco Roviello
Journal:  Arch Surg       Date:  2009-08

7.  Evidence of tumor microsatellite instability in gastric cancer with familial aggregation.

Authors:  Corrado Pedrazzani; Giovanni Corso; Sérgia Velho; Marina Leite; Valeria Pascale; Francesca Bettarini; Daniele Marrelli; Raquel Seruca; Franco Roviello
Journal:  Fam Cancer       Date:  2009-01-17       Impact factor: 2.375

8.  Oncogenic mutations and microsatellite instability phenotype predict specific anatomical subsite in colorectal cancer patients.

Authors:  Giovanni Corso; Valeria Pascale; Giuseppe Flauti; Francesco Ferrara; Daniele Marrelli; Franco Roviello
Journal:  Eur J Hum Genet       Date:  2013-04-10       Impact factor: 4.246

9.  Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer.

Authors:  Alicia Latham; Preethi Srinivasan; Yelena Kemel; Jinru Shia; Chaitanya Bandlamudi; Diana Mandelker; Sumit Middha; Jaclyn Hechtman; Ahmet Zehir; Marianne Dubard-Gault; Christina Tran; Carolyn Stewart; Margaret Sheehan; Alexander Penson; Deborah DeLair; Rona Yaeger; Joseph Vijai; Semanti Mukherjee; Jesse Galle; Mark A Dickson; Yelena Janjigian; Eileen M O'Reilly; Neil Segal; Leonard B Saltz; Diane Reidy-Lagunes; Anna M Varghese; Dean Bajorin; Maria I Carlo; Karen Cadoo; Michael F Walsh; Martin Weiser; Julio Garcia Aguilar; David S Klimstra; Luis A Diaz; Jose Baselga; Liying Zhang; Marc Ladanyi; David M Hyman; David B Solit; Mark E Robson; Barry S Taylor; Kenneth Offit; Michael F Berger; Zsofia K Stadler
Journal:  J Clin Oncol       Date:  2018-10-30       Impact factor: 50.717
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.